Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer

NCT02483104 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02483104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02483104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer
Lead sponsor
AbbVie
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2015
Completion date
July 31, 2016
Enrollment
9 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer